Biohit Partners with Dynex Technologies to Distribute Automated ELISA Processing Systems with GastroPanel

        Print
| Source: Biohit Oyj
multilang-release

Biohit Oyj Press Release December 4, 2013 at 12:45 p.m. local time (EET)

Finnish healthcare company Biohit Oyj and American company Dynex Technologies, Inc. have signed an agreement for the distribution of the two-microplate DS2®, four-microplate DSX® and 12-microplate Agility® automated ELISA (enzyme-linked immunosorbent assay) processing systems, for use with the Biohit Oyj GastroPanel. The agreement gives Biohit Oyj rights to distribute Dynex automated ELISA systems worldwide, effective immediately.

The Dynex automated ELISA systems, as part of the Biohit product portfolio, will improve the availability and usability of the GastroPanel. With the help of this integrated system solution, small and medium-sized laboratories will be able to perform GastroPanel easily and cost-effectively.

CEO Semi Korpela, Biohit Oyj: ”Automated systems save time and resources, eliminate human errors, increase work safety and ensure high-quality results”.

Vice President of Sales & Marketing Duane Steele, Dynex: “Dynex is delighted to cooperate with Biohit to add the GastroPanel to our list of validated assays for our systems, further strengthening Dynex’s position as the global market leader in fully automated ELISA processing for the clinical market.”
 

Additional information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
semi.korpela@biohit.fi
www.biohithealthcare.com
 

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company established in 1988. Biohit's mission is "Innovating for Health". The purpose of the company is to take social responsibility and produce innovation, new technologies and analysis systems for use in medicine, research institutions and industry, helping to promote research and diagnostics and to improve the quality of life of people by means of preventing disease, human suffering and financial loss. We are committed to social responsibility and it is our duty to spread knowledge about the Group I human carcinogen, acetaldehyde, and innovate and develop the marketing and availability of our products and services. Biohit is headquartered in Helsinki, Finland and its subsidiaries are located in China, Italy and the United Kingdom. Since 1999, Biohit's Series B shares (BIOBV) have been listed in the NASDAQ OMX Helsinki Oy Small cap/Healthcare sector. www.biohithealthcare.com


Dynex Technologies in brief

Dynex (www.dynextechnologies.com) pioneered microplate technology more than 50 years ago, and has since delivered a series of cutting edge, best-of-class processing systems, including the 4-plate DSX and 2-plate DS2 systems, and the newly released Agility 12-plate system.  Dynex designs each of its products to meet the rigorous demands of scientists in clinical, biomedical, and pharmaceutical development applications.  Dynex is based in Chantilly, Virginia, USA, with locations in Hong Kong, Germany and the UK, and markets its products worldwide.